How is discussion on HN different from the leadership levels at FDA?<p>Very different. Decisions with enormous health implications, enormous financial implications, are made at FDA.<p>At HN, most people are here to learn, here to understand more.<p>Vinay Prasad is a fraud, completely unfit for the leadership role he was placed into, making baffling and arbitrary decisions on his own, overturning those with far more experience, knowledge and expertise.<p>If a HN comment gets things wrong, a few people might be misinformed, if they are credulous enough to not double check things.<p>When the FDA makes decisions like they have been making, thousands to millions of peoples' lives are worse off, and billions in capital is wasted.<p>Discussion forums of all sorts are incredibly valuable, even when they get things wrong. I have lots of complaints about the overhyping of, say, CRISPR, especially on HN, but whatever, it's a far far higher signal-to-noise than a random person I meet around town. Mention you work on drug development for big pharma to the random person and they think you're evil, at least HN is less likely to have that basic misconception.
> Mention you work on drug development for big pharma to the random person and they think you're evil<p>this <i>is</i> how Martin Shkreli described his work of identifying drug patents to buy that he could jack up the prices on. If that's the extent of the description you gave, I think random people would be right to first think you are doing something evil
> <i>Vinay Prasad is a fraud</i><p>What’s with him being allowed to continue to practice at the University of California [1]?<p>[1] <a href="https://vinayakkprasad.com/" rel="nofollow">https://vinayakkprasad.com/</a>
That is a good question, and I'm sure many of the people at UCSF are asking similar questions. However, his sort of misconduct is not the type that would usually violate tenure protections. Beyond the minor CV fibbing, without some evidence that he actually, say, solicited a bribe from Moderna, it's unlikely that he can face any sort of official sanction.<p>The fraud is in his supposed thrust towards better scientific rigor when he is so sloppy with major decisions of life and death.<p>Just as the comment up there says that HN comments that are critical and misinformed get a lot of attention and upvotes, Prasad has been highly critical and misinformed about scientific research, and his stint at the FDA has exposed that his critiques are much like that top-level HN comment that doesn't get things quite right.
> <i>not the type that would usually violate tenure</i><p>How can one tell whether he has tenure?
For normal research universities, like UCSF, the titles of Professor and Associate Professors have tenure. Assistant Professors are tenure-track, meaning that they have the chance to get tenure. Prasad has the title of Professor.
> he is so sloppy with major decisions of life and death<p>To be clear, the FDA regulates marketing claims. “Is the label accurate?”<p>Major decisions about life and death are between the doctor and the patient, not the FDA.<p>It sounds like you’re taking an expansive view of this government agency’s mandate. People will push back on this at the ballot box, even if they can’t put it to words themselves.
The FDA regulates which drugs make it to market which is itself an <i>extremely</i> powerful force (excessively so) on conversations between you and your doctor.<p>In the case of vaccines, FDA's decisions can quite obviously make a difference in whether we have a rampant lethal pathogen roaring through our schools and killing our children and elderly... or not.<p>It's pedantic to the point of being outright false to say the FDA is not involved in major decisions of life and death. Silly take.
I’m curious why you claim he’s a fraud, I just learned about him from this thread.
Prasad, to the extent he had a reputation before, was for critiquing the scientific practice as inadequate, which would hope that he'd bring the idea of rigor to his stint at the FDA. Instead, we see quite the opposite:<p>- This baffling Moderna decision, which is so bad that many in the industry assumed it was from a failed bribe solicitation<p>- Linked in this article is the "truly evil" decision requiring sham brain surgery in the placebo arm for a Huntington Disease trial <a href="https://arstechnica.com/health/2026/06/truly-evil-fda-rejection-of-gene-therapy-overturned-after-trump-official-ousted/" rel="nofollow">https://arstechnica.com/health/2026/06/truly-evil-fda-reject...</a><p>- Prasad holding a defamatory PR event about the company producing the HD candidate treatment, and only talking "on background" to hide his identity, which is sleazy and unethical "The criticism apparently struck a nerve with Prasad. The FDA held a press briefing later Thursday in which an unnamed “senior FDA official”—who identified himself as a hematology-oncologist—launched into a diatribe against UniQure, saying its “failed therapy” was supported by “distorted and manipulated” data. As for Woodcock’s comments, the official said he “expect[s] better” from her." <a href="https://arstechnica.com/health/2026/03/trumps-divisive-fda-vaccine-regulator-self-destructs-will-exit-agency-again/" rel="nofollow">https://arstechnica.com/health/2026/03/trumps-divisive-fda-v...</a><p>- His first ouster and reinstatement last year, over a unilateral Duchenne muscular dystrophy decision, severely lacking in scientific rigor and analysis<p>- Lied on his CV about being on a highly prestigious council he was not on (The Cancer Letter is not a random YouTube channel, it's high quality cancer research journalism) <a href="https://www.youtube.com/watch?v=pCASAb7J-LE&t=41" rel="nofollow">https://www.youtube.com/watch?v=pCASAb7J-LE&t=41</a><p>As is often the case with such contrarians and critics, their own critiques apply most aptly to themselves.
Imagine being able to shut down discussion at the FDA because a few anonymous randos pushed a "flag" button when they saw something they disagreed with.
People making decisions at the FDA should <i>also</i> be actively learning and understanding more all the time.<p>That should be their primary objective.
> Decisions with enormous health implications, enormous financial implications, are made at FDA.<p>Yes, I started writing that and didn't finish the sentence (see my edit near the end of the GP).<p>But I don't let HN off the hook: The attitude I described in the GP represents and perpetrates the same outlook that politically supports or tolerates this behavior from the FDA. HN users generally legitimize that approach rather than discrediting it.<p>> Mention you work on drug development for big pharma to the random person and they think you're evil<p>I think that's paranoid: The random person won't know what that means. Few who know will also know or care about the social implications. Of those who do, only some will be knee-jerk critical of big pharma, and fewer still of research rather than the business side. It's also a victim perspective: Big Pharma has enormous power; punching up at power by questioning, criticizing, and being skeptical (or even cynical) is not at all the same thing as punching down at the vulnerable. If someone wants the power and resources and salary of Big Pharma, benefitting from its enormous power, the pushback and reputation impact comes with it (though the latter is usually positive - great resume material and credibility).